Chargement en cours...
Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes.
OBJECTIVES: We focused on four questions: What are the risks and benefits of an oral diabetes agent (i.e., glyburide), as compared to all types of insulin, for gestational diabetes? What is the evidence that elective labor induction, cesarean delivery, or timing of induction is associated with benef...
Enregistré dans:
| Publié dans: | Evid Rep Technol Assess (Full Rep) |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
United States. Agency for Healthcare Research and Quality
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4781072/ https://ncbi.nlm.nih.gov/pubmed/18457474 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|